Related Experiment Video
Updated: Aug 1, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Heart failure and diabetes: pathogenesis and management
1Krannert Institute of Cardiology and Clinical Cardiology Research VA Medical Center, Indiana University School of Medicine Indianapolis, IN 46202, USA. Masoor.kamalesh@med.va.gov
Insights
Diabetes significantly increases mortality in patients with congestive heart failure (CHF). Managing diabetes and related conditions is crucial for preventing heart failure in diabetic individuals.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- The incidence of diabetes is rising globally, leading to a growing population with both diabetes and congestive heart failure (CHF).
- Diabetic patients with CHF experience approximately 30% higher mortality rates compared to non-diabetic individuals, despite therapeutic advancements.
- Ischemic heart disease and left ventricular dysfunction are key mechanisms contributing to CHF development in diabetic patients.
Purpose of the Study:
- To review recent advancements in the management of congestive heart failure (CHF) in diabetic patients.
- To highlight the importance of managing diabetes and comorbidities in preventing CHF.
- To discuss new developments in treating asymptomatic left ventricular dysfunction and established CHF.
Main Methods:
- This review synthesizes current literature and clinical trial data.
- It focuses on the interplay between diabetes, coronary artery disease, and heart failure.
- The review examines evolving treatment strategies for left ventricular dysfunction and CHF.
Main Results:
- Diabetes is a significant risk factor for developing CHF and is associated with poorer outcomes.
- Effective management of diabetes and comorbidities is essential for CHF prevention.
- Recent clinical trials have advanced the understanding and treatment of CHF in diabetic populations.
Conclusions:
- Physicians will increasingly encounter patients with the co-occurrence of diabetes, coronary disease, and heart failure.
- Proactive management of diabetes and associated conditions is critical for mitigating CHF risk.
- Ongoing research and evolving treatment protocols offer improved management strategies for diabetic patients with CHF.
Abstract:
The incidence of diabetes among patients with congestive heart failure (CHF) is increasing. Despite advances in therapy for CHF, mortality remains about 30% higher for diabetics with CHF than non-diabetics. Multiple mechanisms are responsible for development of CHF in diabetes with ischemic heart disease and its attendant complication of left ventricular dysfunction playing a major role. The prevalence of diabetes is rising worldwide. Thus in the foreseeable future, it appears that physicians will have to deal with increasing numbers of subjects with diabetes, coronary disease and heart failure. Management of diabetes and co-morbid conditions plays a vital role in the prevention of development CHF in subjects with diabetes. Treatment of asymptomatic left ventricular dysfunction and management of CHF has been evolving over last few years with major clinical trials advancing our knowledge. This review highlights some of the new developments in this field.
Related Concept Videos
Pathophysiology of Heart Failure
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions

